Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.

Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.

Trypanosoma cruzi is the causal agent of Chagas Disease that is endemic in Latin American, afflicting more than ten million people approximately. This disease has two phases, acute and chronic. The acute phase is often asymptomatic, but with time it progresses to the chronic phase, affecting the hea...

Full description

Bibliographic Details
Main Authors:	Carolina Campos-Estrada, Ana Liempi, Fabiola González-Herrera, Michel Lapier, Ulrike Kemmerling, Barbara Pesce, Jorge Ferreira, Rodrigo López-Muñoz, Juan D Maya
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-05-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4433340?pdf=render

Similar Items

Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.
by: Alfredo Molina-Berríos, et al.
Published: (2013-01-01)

Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
by: Davi Alvarenga Lima, et al.
Published: (2023-05-01)

Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics.
by: Andrea Trochine, et al.
Published: (2014-05-01)

Endogenous overexpression of an active phosphorylated form of DNA polymerase β under oxidative stress in Trypanosoma cruzi.
by: Diego A Rojas, et al.
Published: (2018-02-01)

Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection
by: Xiaomo Li, et al.
Published: (2021-05-01)

Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
by: Denise da Gama Jaén Batista, et al.
Published: (2011-01-01)

Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains
by: Veloso VM, et al.
Published: (2001-01-01)

Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice
by: Beatriz Matheus Souza Gonzaga, et al.
Published: (2022-12-01)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
by: Julián Ernesto Nicolás Gulin, et al.
Published: (2022-07-01)

Trypanosoma cruzi and Toxoplasma gondii Induce a Differential MicroRNA Profile in Human Placental Explants
by: Lisvaneth Medina, et al.
Published: (2020-11-01)

Host–Pathogen Interaction Involved in <i>Trypanosoma cruzi</i> Infection
by: Christian Castillo, et al.
Published: (2022-05-01)

A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
by: Bianca Zingales, et al.
Published: (2015-05-01)

Benznidazole Treatment: Time- and Dose-Dependence Varies with the <i>Trypanosoma cruzi</i> Strain
by: Kátia da Silva Fonseca, et al.
Published: (2021-06-01)

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
by: Elena Aguilera, et al.

Molecular characterization of the hexose transporter gene in benznidazole resistant and susceptible populations of <it>Trypanosoma cruzi</it>
by: dos Santos Paula F, et al.
Published: (2012-08-01)

Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
by: Angela Maria Lourenço, et al.

Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
by: Vanesa Puente, et al.
Published: (2018-09-01)

The Influence of Milling on the Dissolution Performance of Simvastatin
by: Thomas Rades, et al.
Published: (2010-12-01)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
by: Hanson Mary E, et al.
Published: (2010-07-01)

Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction.
by: Wallace, S, et al.
Published: (2010)

Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption.
by: Marsha C Lampi, et al.
Published: (2016-01-01)

Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain.
by: Nathaniel Shryock, et al.
Published: (2013-01-01)

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
by: Margoth Moreno, et al.
Published: (2010-11-01)

Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain
by: Edson L.P. Camandaroba, et al.
Published: (2003-04-01)

Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells
by: Juliana Magalhães Chaves Barbosa, et al.
Published: (2022-08-01)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
by: Tassiane Assíria Fontes Martins, et al.
Published: (2015-01-01)

Anti-inflammatory effect of simvastatin by impeding TNF-α and interleukin-1ß pathways: antiangiogenic activity of simvastatin and simvastatin-loaded silver nanoparticles
by: Manal Buabeid, et al.
Published: (2022-12-01)

Endothelial transmigration by Trypanosoma cruzi.
by: Bria M Coates, et al.
Published: (2013-01-01)

Infection and invasion mechanisms of Trypanosoma cruzi in the congenital transmission of Chagas' disease: A proposal
by: Ulrike Kemmerling, et al.
Published: (2010-01-01)

Encapsulation of benznidazole in nanostructured lipid carriers and increased trypanocidal activity in a resistant Trypanosoma cruzi strain
by: Flávia Lidiane Oliveira da Silva, et al.
Published: (2023-05-01)

Old Yellow Enzyme from Trypanosoma cruzi Exhibits In Vivo Prostaglandin F2α Synthase Activity and Has a Key Role in Parasite Infection and Drug Susceptibility
by: Florencia Díaz-Viraqué, et al.
Published: (2018-03-01)

Ex Vivo Infection of Human Placental Explants by <i>Trypanosoma cruzi</i> Reveals a microRNA Profile Similar to That Seen in Trophoblast Differentiation
by: Lisvaneth Medina, et al.
Published: (2022-03-01)

Trypanocidal activity of genotoxic concentration of benznidazole on epimastigote forms of Trypanosoma cruzi = Atividade tripanocida da concentração genotóxica do benzonidazol em formas epimastigotas de Trypanosoma cruzi
by: Edilson Nobuyoshi Kaneshima, et al.
Published: (2012-10-01)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display.
by: Luis Antonio Rodriguez Carnero, et al.
Published: (2023-01-01)

Sensibilidad in vitro a benznidazol, nifurtimox y posaconazol de cepas de Trypanosoma cruzi de Paraguay
by: Nidia Acosta, et al.
Published: (2020-12-01)

Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias
by: Sonia G. Andrade, et al.
Published: (2003-07-01)

High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala
by: Lucia Brum-Soares, et al.

Prostaglandin F2α synthase in Trypanosoma cruzi plays critical roles in oxidative stress and susceptibility to benznidazole
by: Paola García-Huertas, et al.
Published: (2017-01-01)

In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.
by: Andrea Vela, et al.
Published: (2021-03-01)

Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study.
by: Lisandro D Colantonio, et al.
Published: (2016-05-01)